Search

everythinglearnresearchcommunity

for

Search:↓

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The treatment successfully lowered testosterone levels and reduced symptoms.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

The girl's hirsutism and menstrual issues were caused by a benign ovarian tumor, which was successfully removed.

Nutraceuticals can effectively manage hormonal imbalances and related health issues.

Postmenopausal women with unusual hair growth should be checked for ovarian tumors.

Gene mutations can cause problems in male genital development.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Losing weight and taking birth control pills can greatly improve severe male hormone excess in women with PCOS.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

Hormonal imbalance contributes to chronic prostatitis and affects male reproductive health.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

PCOS is a common disorder in women causing hormonal imbalance and fertility issues, often managed with lifestyle changes and medication.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.